Quest Diagnostics Inc (DGX)

91.14
NYSE : Health Care
Prev Close 89.68
Day Low/High 89.45 / 91.23
52 Wk Low/High 59.66 / 91.23
Avg Volume 1.15M
Exchange NYSE
Shares Outstanding 138.64M
Market Cap 12.43B
EPS 4.90
P/E Ratio 19.04
Div & Yield 1.80 (2.00%)

Latest News

Quest Diagnostics CEO on Donald Trump's Plan to Overhaul Obamacare

Quest Diagnostics CEO on Donald Trump's Plan to Overhaul Obamacare

Quest Diagnostics CEO Stephen Rusckowski discusses the Affordable Care Act and what's next for his company.

Starbuck's caffeinated profits

Starbuck's caffeinated profits

Starbucks comes through with another dividend hike

Higher Hiring: How Weed Can Lure Retirees Back to the Workforce

Higher Hiring: How Weed Can Lure Retirees Back to the Workforce

More medical marijuana use could increase the supply of workers, says a new study. But there are some issues, not the least of which are varying legal standards.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.

What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers

What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers

Quest and IBM are rolling out a genomic sequencing service powered by Big Blue's Watson supercomputer.

IBM And Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service To Help Physicians Bring Precision Cancer Treatments To Patients Nationwide

IBM And Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service To Help Physicians Bring Precision Cancer Treatments To Patients Nationwide

Memorial Sloan Kettering Cancer Center to Provide Deep Knowledge Base to Augment Watson's Data Sources and Quest's Medical Reporting

'Mad Money' Lightning Round: AMD Is Coming Back

'Mad Money' Lightning Round: AMD Is Coming Back

Cramer says Quest Diagnostics has gone up by too much while he likes Cerner for the long term.

Jim Cramer's 'Mad Money' Recap: Here's My Game Plan for Next Week

Jim Cramer's 'Mad Money' Recap: Here's My Game Plan for Next Week

Cramer says his game plan is all about earnings, when the fundamentals control the market.

Quest Diagnostics Becomes #90 Most Shorted S&P 500 Component, Replacing The Gap

Quest Diagnostics Becomes #90 Most Shorted S&P 500 Component, Replacing The Gap

The most recent short interest data has been released for the 09/30/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

These 5 Rocket Stocks Are Ready for Blastoff This Fall

These 5 Rocket Stocks Are Ready for Blastoff This Fall

These stocks have both short-term gain catalysts and longer-term growth prospects.

Quest Diagnostics Launches Zika Antibody Test Service Based On The CDC MAC-ELISA Antibody Test

Quest Diagnostics Launches Zika Antibody Test Service Based On The CDC MAC-ELISA Antibody Test

Company also introduces molecular Zika testing for serum and paired urine

Drug Positivity In U.S. Workforce Rises To Nearly Highest Level In A Decade, Quest Diagnostics Analysis Finds

Drug Positivity In U.S. Workforce Rises To Nearly Highest Level In A Decade, Quest Diagnostics Analysis Finds

Annual Drug Testing Index Reveals Fifth Straight Year of Increases in Detection Rate of Amphetamine and Heroin; Marijuana Positivity Increases 47 Percent Since 2013 in Oral Fluid Testing

Short Interest In Quest Diagnostics Moves 13.2% Lower

Short Interest In Quest Diagnostics Moves 13.2% Lower

The most recent short interest data has been released for the 08/31/2016 settlement date, which shows a 855,753 share decrease in total short interest for Quest Diagnostics, Inc. , to 5,618,473, a decrease of 13.22% since 08/15/2016.

Optum And Quest Diagnostics Partner To Help Make The Health System Work Better For Patients, Physicians, Health Plans And Employers

Optum And Quest Diagnostics Partner To Help Make The Health System Work Better For Patients, Physicians, Health Plans And Employers

Optum, a leading information and technology-enabled health services business, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced they will partner to help make...

How to Cash in on the Fight Against the Zika Virus

How to Cash in on the Fight Against the Zika Virus

Where some see danger and upheaval, investors see opportunity. And the harrowing Zika virus is no different. Investors are jumping into stocks focused on detecting or wiping out the virus.

Sonora Quest Laboratories and Safeway Expand Highest-Quality Diagnostic Testing to Greater Arizona

Sonora Quest Laboratories and Safeway Expand Highest-Quality Diagnostic Testing to Greater Arizona

New Service Centers Offer Retail Convenience, With or Without a Doctor's Order

Quest Diagnostics Approved To Use Electronic Drug Test Process For Federally-Mandated Workforce By U.S. Health And Human Services

Quest Diagnostics Approved To Use Electronic Drug Test Process For Federally-Mandated Workforce By U.S. Health And Human Services

eCCF dramatically improves efficiency and time savings in workplace drug testing

5 Big Stocks to Buy for Big Gains

5 Big Stocks to Buy for Big Gains

These stocks have both short-term gain catalysts and longer-term growth potential.

Quest Diagnostics Launches New Digital Dementia Assessment Test To Aid Physicians' Assessment Of Individuals With Cognitive Dysfunction

Quest Diagnostics Launches New Digital Dementia Assessment Test To Aid Physicians' Assessment Of Individuals With Cognitive Dysfunction

First digital testing technology from diagnostics leader is designed to help primary care physicians and ACOs improve the detection and monitoring of patients with dementias such as Alzheimer's disease

Quest Diagnostics And AncestryDNA Collaborate To Expand Consumer DNA Testing

Quest Diagnostics And AncestryDNA Collaborate To Expand Consumer DNA Testing

World leaders in consumer genomics and diagnostic information services team up

Starbucks takes on the world

Starbucks takes on the world

Starbucks has a big future in China, India and Africa

Insider Trading Alert - TUP, DGX And EXPO Traded By Insiders

Insider Trading Alert - TUP, DGX And EXPO Traded By Insiders

Stocks with insider trader activity include TUP, DGX and EXPO

Data Diagnostics Healthcare Technology Wins Two Gold Honors For Innovation In The 2016 Golden Bridge Awards

Data Diagnostics Healthcare Technology Wins Two Gold Honors For Innovation In The 2016 Golden Bridge Awards

Healthcare analytics technology from Quest Diagnostics and Inovalon supports adoption of value-based care

One In Two American Adults Misuse Their Prescription Drugs, Finds Analysis Of More Than Three Million Lab Tests From Quest Diagnostics

One In Two American Adults Misuse Their Prescription Drugs, Finds Analysis Of More Than Three Million Lab Tests From Quest Diagnostics

Study Finds Sharp Increase in Patients Who Combine Prescribed Medications with Other Drugs; Two in Three Users of Heroin Take it with Benzodiazepines, a Potentially Lethal Combination